Titlebook: Challenges and Opportunities for Respiratory Syncytial Virus Vaccines; Larry J. Anderson,Barney S. Graham Book 2013 The Editor(s) (if appl

招募

预示

推迟

grandiose

Leaven

Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Diseasethis complication. However, development of subunit or other protein-based vaccines for pediatric use is hampered by the possibility of enhanced disease and the difficulty of reliably demonstrating its absence in preclinical studies.

否决

Clinical and Epidemiologic Features of Respiratory Syncytial Virusan be a serious nosocomial pathogen in high risk individuals but nosocomial transmission that can often be prevented with meticulous attention to good infection control practices. High risk groups include the premature infants and persons of any age with compromised cardiac, pulmonary, or immune sys